Your browser doesn't support javascript.
loading
Clinical significance of co-expression of MYC and BCL2 protein in aggressive B-cell lymphomas treated with a second line immunochemotherapy.
Miura, Katsuhiro; Takahashi, Hiromichi; Nakagawa, Masaru; Izu, Asami; Sugitani, Masahiko; Kurita, Daisuke; Sakagami, Masashi; Ohtake, Shimon; Uchino, Yoshihito; Hojo, Atsuko; Kodaira, Hitomi; Yagi, Mai; Kobayashi, Yujin; Iriyama, Noriyoshi; Kobayashi, Sumiko; Kiso, Satomi; Hirabayashi, Yukio; Hatta, Yoshihiro; Takei, Masami.
Afiliación
  • Miura K; a Division of Hematology and Rheumatology , Department of Medicine ;
  • Takahashi H; a Division of Hematology and Rheumatology , Department of Medicine ;
  • Nakagawa M; b Division of Laboratory Medicine , Department of Pathology of Microbiology ;
  • Izu A; a Division of Hematology and Rheumatology , Department of Medicine ;
  • Sugitani M; c Department of Pathology , Nihon University School of Medicine , Tokyo , Japan.
  • Kurita D; c Department of Pathology , Nihon University School of Medicine , Tokyo , Japan.
  • Sakagami M; a Division of Hematology and Rheumatology , Department of Medicine ;
  • Ohtake S; a Division of Hematology and Rheumatology , Department of Medicine ;
  • Uchino Y; a Division of Hematology and Rheumatology , Department of Medicine ;
  • Hojo A; a Division of Hematology and Rheumatology , Department of Medicine ;
  • Kodaira H; a Division of Hematology and Rheumatology , Department of Medicine ;
  • Yagi M; a Division of Hematology and Rheumatology , Department of Medicine ;
  • Kobayashi Y; a Division of Hematology and Rheumatology , Department of Medicine ;
  • Iriyama N; a Division of Hematology and Rheumatology , Department of Medicine ;
  • Kobayashi S; a Division of Hematology and Rheumatology , Department of Medicine ;
  • Kiso S; a Division of Hematology and Rheumatology , Department of Medicine ;
  • Hirabayashi Y; a Division of Hematology and Rheumatology , Department of Medicine ;
  • Hatta Y; a Division of Hematology and Rheumatology , Department of Medicine ;
  • Takei M; a Division of Hematology and Rheumatology , Department of Medicine ;
Leuk Lymphoma ; 57(6): 1335-41, 2016.
Article en En | MEDLINE | ID: mdl-26390147
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Linfoma de Células B / Proteínas Proto-Oncogénicas c-myc / Proteínas Proto-Oncogénicas c-bcl-2 Tipo de estudio: Diagnostic_studies / Prognostic_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Leuk Lymphoma Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2016 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Linfoma de Células B / Proteínas Proto-Oncogénicas c-myc / Proteínas Proto-Oncogénicas c-bcl-2 Tipo de estudio: Diagnostic_studies / Prognostic_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Leuk Lymphoma Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2016 Tipo del documento: Article